|
Real-time Estimate
Cboe BZX
11:38:11 2026-10-19 EDT
|
5-day change | 1st Jan Change | ||
| 0.9500 USD | -2.89% |
|
-0.15% | -42.95% |
| 09-30 | EARNINGS: Generation Essentials interim profit jumps to USD28 million | AN |
| 08-07 | Lineage Cell Therapeutics, Inc., Q2 2026 Earnings Call, Aug 06, 2026 |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -2.89% | -0.15% | -5.67% | -13.39% | -42.95% | -41.91% | -19.26% | -59.63% | -72.70% | 247M | |
| +1.52% | -7.16% | -8.44% | +24.27% | +61.63% | +51.66% | +67.41% | +1.95% | - | 65B | |
| +1.16% | +6.55% | +11.44% | +8.25% | +13.72% | +10.60% | +78.83% | -15.38% | +229.17% | 51.2B | |
| +0.30% | -0.46% | -15.92% | -3.16% | +1.81% | -0.03% | +61.89% | +184.97% | +4,878.17% | 51.19B | |
| -0.64% | +0.89% | -1.97% | +29.74% | +17.36% | +24.76% | +41.66% | +6.24% | +251.75% | 43.93B | |
| +0.23% | +5.62% | +1.21% | +19.16% | +21.82% | +16.16% | +133.25% | -1.57% | +1,027.29% | 41.96B | |
| +2.31% | -6.55% | -5.98% | +0.47% | +127.55% | +235.57% | +524.97% | +559.53% | - | 38.14B | |
| +2.16% | +10.36% | +10.48% | +12.74% | +14.98% | +18.92% | +59.70% | +11.35% | +163.60% | 33.24B | |
| -0.90% | -10.49% | -4.27% | +30.34% | +53.31% | +37.09% | +1.80% | -58.05% | - | 25.2B | |
| +1.60% | +2.21% | +12.48% | +37.63% | +25.41% | +27.96% | +28.00% | -12.65% | +122.01% | 22.5B | |
| +0.40% | -8.08% | -10.10% | -4.41% | -7.46% | -18.39% | -5.51% | -66.48% | - | 22.03B | |
| -0.74% | -3.25% | -21.19% | -10.90% | -45.21% | -43.21% | +277.96% | +257.96% | +599.63% | 21.02B | |
| +0.51% | +0.14% | -0.53% | +17.61% | +10.55% | +14.05% | +170.48% | +234.42% | +1,917.25% | 17.26B | |
| -5.62% | -1.67% | -0.42% | -1.67% | +177.32% | +152.60% | +374.24% | +1,427.38% | +748.34% | 15.9B | |
| +0.46% | +4.46% | +9.21% | +12.53% | +42.57% | +80.92% | +200.00% | +190.65% | +442.45% | 15.42B | |
| +0.87% | +1.65% | +1.13% | +11.03% | +26.51% | +23.54% | +66.26% | -29.05% | +86.95% | 15.28B | |
| +2.10% | +1.25% | -3.26% | -8.71% | - | - | - | - | - | 14.79B | |
| +0.26% | -0.41% | +7.75% | +36.83% | +50.70% | +63.26% | +60.42% | -27.12% | +273.08% | 14.33B | |
| +3.10% | +1.66% | -2.08% | -7.07% | +15.25% | -1.40% | +496.31% | - | - | 13.77B | |
| -0.55% | +2.59% | -0.53% | +1.49% | -7.45% | -10.51% | -25.23% | -39.24% | +114.98% | 13.13B | |
| Average | +0.26% | -0.19% | -1.33% | +9.64% | +29.34% | +33.77% | +136.48% | +142.51% | +770.14% | 26.78B | |
| Weighted average by Cap. | +0.61% | -0.25% | -1.90% | +12.38% | +33.67% | +39.45% | +130.13% | +120.85% | +1,107.49% |
- Stock Market
- Stocks
- LCTX Stock
- Sector Lineage Cell Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
